经直肠多模态超声与多模态MRI检查对前列腺癌诊断价值的对照研究

目的比较经直肠多模态超声与多模态MRI检查对前列腺癌的诊断价值。方法回顾性分析2016年4月至2018年5月解放军总医院第一医学中心收治的102例可疑前列腺癌患者的临床资料。平均年龄66.1(38.0~85.0)岁,PSA平均值30.1(0.4~227.0)ng/ml,PSA密度(PSAD)平均值0.67(0.02~4.27)ng/ml^2。102例均行经直肠多模态超声(经直肠常规超声、剪切波弹性成像和超声造影)、多模态MRI(T2加权成像、弥散加权成像和动态增强)以及实验室检查。以经直肠超声引导穿刺活检或手术病理结果作为金标准,对比经直肠多模态超声与多模态MRI检查诊断前列腺癌的敏感性、特异性、阳性预测值、阴性预测值、准确性和受试者工作特征(receiver operating characteristic,ROC)曲线的曲线下面积。结果102例中,病理诊断为前列腺癌62例,良性前列腺增生(BPH)40例。并联多模态经直肠超声(即经直肠常规超声、剪切波弹性成像和超声造影检查中任一项结果阳性诊断为前列腺癌)诊断前列腺癌63例,BPH 39例;诊断前列腺癌的敏感性、特异性和准确性分别为98.4%、70.0%和87.3%。多模态MRI检查诊断前列腺癌75例,BPH 27例;诊断前列腺癌的敏感性、特异性和准确性分别为95.2%、60.0%和81.4%。并联多模态经直肠超声和多模态MRI检查诊断前列腺癌ROC曲线的曲线下面积分别为0.842和0.776,差异无统计学意义(P=0.208)。结论并联多模态经直肠超声检查诊断前列腺癌的效能不亚于多模态MRI检查。

Comparative study on the diagnostic value of multiparametric transrectal ultrasound and multiparametric MRI in prostate cancer

Objective The aim of the study is to compare the diagnostic value of multiparametric transrectal ultrasound(TRUS)and multiparametric magnetic resonance imaging(MRI)in prostate cancer.Methods The clinical data of 102 patients who received multiparametric TRUS(including conventional transrectal ultrasound,shear wave sonoelastography and contrast enhanced ultrasound),multiparametric MRI(including T2 weighted diffusion weighted,and dynamic contrast enhanced MRI)and laboratory tests from April 2016 to May 2018 were retrospectively analyzed.The average age was 66.1 years old,ranging 38.0-85.0 years old.The average PSA was 30.1 ng/ml,ranging 0.4-227.0 ng/ml.The average PSAD was 0.67 ng/ml^2,ranging 0.02-4.27 ng/ml2.The pathology results from TRUS guided biopsy or surgical operation were chosen as gold standard.Diagnostic performance including sensitivity,specificity,positive predictive value(PPV),negative predictive value(NPV),accuracy and area under the receiver operating characteristic curve(AUROC)of multiparametric TRUS and multiparametric MRI in prostate cancer were analyzed.Results There were 62 prostate cancer and 40 BPH patients in our study.Parallel multiparametric TRUS diagnosed 63 prostate cancer and 39 BPH,and multiparametric MRI diagnosed 75 prostate cancer and 27 BPH.The sensitivity,specificity and accuracy of parallel multiparametric TRUS were 98.4%,70.0%and 87.3%,respectively.And those of multiparametric MRI were 95.2%,60.0%and 81.4%,respectively.The AUROC of parallel multiparametric TRUS and multiparametric MRI were 0.842 and 0.776,with no significant differences(P=0.208).Conclusion The diagnostic value of multiparametric TRUS was not inferior to multiparametric MRI in prostate cancer.